Safety of Combined Treatment With Monoclonal Antibodies and L Preparations
Combination strategies involving chemotherapy and monoclonal antibodies (mAb) are commonly used in attempts to produce better clinical outcomes. This practice has led to new and ongoing toxicities that may lead to reductions in dose or noncompliance, limiting the effectiveness of treatment. Viscum a...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2018-03-01
|
| Schriftenreihe: | Integrative Cancer Therapies |
| Online-Zugang: | https://doi.org/10.1177/1534735416681641 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|